Mr. Andrew D. Dickinson is a President, Treasurer & Director at Immunomedics, Inc., a President, Treasurer & Director at Forty Seven, Inc. and a Chief Financial Officer at Gilead Sciences, Inc. He is on the Board of Directors at Immunomedics, Inc., Forty Seven, Inc., Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. Mr. Dickinson was previously employed as a Founding Partner by Kendall Dickinson & Koenig LLC, a Secretary, Vice President & General Counsel by Myogen, Inc., and a Co-Head-Healthcare Investment Banking by Lazard Ltd. He received his undergraduate degree from The University of Colorado and a graduate degree from Loyola University of Chicago.